Cone photoreceptors in the retina enable vision over a wide range of light intensities. However, the processes enabling cone vision in bright light (i.e. photopic vision) are not adequately understood. Chromophore regeneration of cone photopigments may require the retinal pigment epithelium (RPE) and/or retinal Müller glia. In the RPE, isomerization of all-trans-retinyl esters (atRE) to 11-cis-retinol (11cROL) is mediated by the retinoid isomerohydrolase Rpe65. An alternative retinoid isomerase, dihydroceramide desaturase-1 (DES1), is expressed in RPE and Müller cells. The retinol-isomerase activities of Rpe65 and Des1 are inhibited by emixustat and fenretinide, respectively. Here, we tested the effects of these visual cycle inhibitors on immediate, early and late phases of cone photopic vision. In zebrafish larvae raised under
cyclic light conditions, fenretinide impaired late cone photopic vision, whereas emixustat-treated zebrafish unexpectedly had normal vision. In contrast, emixustat-treated larvae raised under extensive dark-adaption displayed significantly attenuated immediate photopic vision concomitantly with significantly reduced 11-cisretinaldehyde (11cRAL). Following 30 minutes of light, early photopic vision recovered, despite 11cRAL levels remaining significantly reduced. Defects in immediate cone photopic vision were rescued in emixustat-or fenretinide-treated larvae following exogenous 9-cis-retinaldehyde (9cRAL) supplementation. Genetic knockout of degs1 or retinaldehyde-binding protein 1b (rlbp1b) revealed that neither are required for photopic vision in zebrafish. Our findings define the molecular and temporal requirements of the non-photopic and photopic visual cycles for mediating vision in bright light.
Introduction
Photopic vision is the physiological function mediating vision in well-lit conditions. Daytime vision requires cone photoreceptors to remain functional in the presence of light. This capability requires regeneration of cone photopigments in the retina prior to and during light onset. However, our understanding of the biological process contributing to immediate, early and late phases of cone photopic vision is inadequate.
Visual Cycles in RPE and Müller cells
Sustained vision in vertebrates depends upon a supply of 11-cis-retinaldehyde (11cRAL) chromophore to regenerate photobleached visual pigments. The canonical visual cycle is the enzymatic pathway in the retinal pigment epithelium (RPE) that recycles visual chromophore (1) . The retinoid isomerase in RPE cells is RPE65, which converts all-trans retinyl esters (atREs), synthesized by lecithin-retinol acyltransferase (LRAT), to 11-cis-retinol (11cROL) (2) (3) (4) . Null mutations in the mouse Rpe65 or Lrat gene cause the virtual absence of 11cRAL within the neural retina (5, 6) . Rpe65 -/mice exhibit massive accumulation of atREs in the RPE, while retinoids are almost undetectable in RPE of Lrat -/mice (7, 8) . Notably, there is still uncertainty as to if, and when, the RPE65 visual cycle contributes to cone photopic vision.
Under daylight conditions, the estimated rate of 11cRAL synthesis by RPE cells is much slower than the rate of chromophore consumption by rods and cones (9) . Despite the non-contribution of rods to daylight vision, rhodopsin continues to photoisomerize in brightlight exposed retinas. Cones must therefore compete with rods for chromophore when demand is highest. As a possible adaptation, cones can regenerate cone-opsin pigments by uptake of either 11cRAL or 11cROL, while rods can only uptake 11cRAL (10) (11) (12) . Müller glial cells of the neural retina are the likely source of this 11cROL (13) . Dihydroceramide desaturase (DES1; encoded by DEGS1) and multifunctional O-acyltransferase (MFAT) represent another retinol isomerase-retinyl-ester synthase pair, present in Müller cells, which may mediate 11cROL synthesis. The 'isomerosynthase' activity of DES1-MFAT is present in retinas from cone-dominant chickens and ground squirrels, but undetectable in retinas from roddominant mice and cattle (9, 14) . This activity correlated with the presence of 11-cis-retinyl esters (11cREs) in the neural retina, which are undetectable in mice and cattle retinas. Interestingly, synthesis of 11cROL by DES1 is increased through interactions with cellular retinaldehyde binding protein (CRALBP; encoded by RLBP1) an 11cRAL/11cROL carrier protein expressed in the RPE and Müller glia (15) .
In contrast to the evidence supporting a role for DES1 in cone chromophore regeneration, a recent study reported that recovery of cone electrophysiological sensitivity, in isolated retinas following a photobleach, was similar in Des1 +/+ and Müller-cell conditional Des1 -/mutant mice (16) . This suggests Müller DES1 plays no role in the generation of retinoids to recover mouse cone electroretinograms. However, uncertainty remains regarding the overall contribution of DES1 to the cone visual cycle as significant DES1 activity remained in retinal lysates of these Müller-cell Des1 -/mice.
Additionally, the cone electrophysiological studies were conducted in rod-dominant mice whereas DES1 was identified in Müller cells from cone-dominant chicken. Thus, uncertainly remains as to whether speciesspecific retinoid isomerase pathways exist to meet cone chromophore demands.
A third mechanism postulated to replenish cones with chromophore is the photopic visual cycle, a process that regenerates 11cRAL by a light-dependent mechanism. The non-visual opsin, retinal G protein-coupled receptor (RGR) opsin is present in RPE and Müller cells. Previous reports show RGR-opsin is integral to light-dependent biochemical formation of 11cRAL that reconstitutes rhodopsin visual pigment in rods (17) . RGRopsin appears essential for the recovery of cone electrophysiological sensitivity as retinas from wild-type mice under sustained background illumination maintained cone sensitivity, while Rgr -/mice exhibited diminishing cone sensitivity during light exposure (18) . Notably, all these studies assess cone electroretinography (ERG) and not cone vision. It is well recognized that electrophysiology does not absolutely correlate to functional vision. For example, patients receiving gene therapy for RPE65 defects show no improvement in ERG but show significant improved ability to navigate an obstacle course (19) .
In Vivo Cone Models
Most visual cycle knowledge was ascertained by studying retinae of rod dominant mice. Consequently, investigations of the visual cycles enabling cone vision are less advanced. Zebrafish larvae provide novel opportunities to study cone photopic vision and the supporting visual cycle processes (20) due to easy genetic and pharmacological manipulation, and conedominant vision until 15 dpf, the stage when rods become functional (21, 22) . Previous studies investigating visual cycle components in zebrafish relied on transient morpholino knockdown. Zebrafish rpe65a knockdown significantly reduced, but did not completely attenuate 11cRAL synthesis, supporting the presence of an alternate pathway for chromophore synthesis in zebrafish retinae (20) . Knockdown of either Cralbpa or Cralbpb in zebrafish resulted in reduced visual behavior (23) and reduced light sensitivity (24).
Visual Cycle Modulation
Pharmacological modulators that inhibit or complement the visual cycles are potential treatments for retinal disease (25, 26) . Following photoisomerization, released atRAL must be delivered to RPE/Müller cells to regenerate 11cRAL to restore light sensitivity. Impaired atRAL clearance from photoreceptors leads to accumulation of bis-retinoid N-retinylidene-Nretinylethanolamine (A2E), a toxic by-product of atRAL and a pathological hallmark of agerelated macular degeneration (AMD) and Stargardt disease (27) . Emixustat (ACU-4429) competitively inhibits Rpe65 and hinders retinaldehyde-mediated destruction of photoreceptors by acting as a retinaldehyde scavenger (26) . Inhibition of chromophore synthesis gives rise to unliganded 'noisy' opsins that stimulate the transduction pathway in the absence of light, greatly decreasing photoreceptor sensitivity (28) . In Rpe65 -/mice, chronic activation of signal transduction may cause photoreceptor degeneration (29) . Free opsin can be targeted by chromophorereplacement therapy with 9cRAL, which bypasses the visual cycle defect to form isorhodopsin or iso-cone-opsins. Following 9cRAL treatment, light sensitivity is restored long-term in Rpe65 -/mice with attenuated accumulation of atREs (30) . Fenretinide (4-HPR), a derivative of retinoic acid is reported to inhibit DES1 without affecting RPE65 activity (31) (32) (33) . Fenretinide also competes with retinol for binding to retinol-binding protein (RBP4) in blood, causing a mild vitamin A deficiency (34) . A1120 is a non-retinoid RBP4 antagonist which in mice reduces serum retinol levels in a dosedependent manner (35) and reduces lipofuscin accumulation in Abca4 -/mice through reduction of serum RBP4 and visual retinoids (34) . Unlike fenretinide, A1120 does not act as a retinoic acid receptor alpha agonist. A1120 does not affect RPE65 isomerohydrolase activity in ex vivo experiments (34) .
Previous visual cycle inhibition studies focused on measuring retinal function (e.g. electrophysiology) as the primary endpoint. Reduced cone photosensitivity was observed in live mice and isolated retinas treated with visual cycle inhibitors (32) . To our knowledge, no previous studies investigated the relationship between visual cycle modulation and cone photopic vision. In the current study, we used visual behavior assays, visual cycle inhibitors and genetic approaches in zebrafish to understand the mechanisms regulating immediate (at light onset following dark adaptation, 0 minutes), early (after 30 minutes light adaptation) or late (after ~4-6 hours light adaptation) phases of cone photopic vision. Original findings were uncovered in relation to cone photopic vision, including: i) late photopic vision is significantly impaired by fenretinide, but not by emixustat, ii) immediate photopic vision is reliant on Rpe65, iii) 30 mins of light is sufficient to restore early photopic vision and surmount the RPE65 inhibitor emixustat iv) the RPE65-independent recovery of early photopic vision occurs with low levels of 11cRAL, v) exogenous 9cRAL is sufficient to restore photopic vision and vi) photopic vision does not rely on degs1 or RPE-expressed rlbp1b.
Results

Fenretinide, but not emixustat, impairs late cone photopic vision in zebrafish larvae
To investigate the effects of visual cycle inhibitors on cone vision, we assayed the effects of pharmacological agents, previously used in human clinical trials (36, 37) , on the vision of 5 dpf zebrafish larvae. Previous studies demonstrate 5 dpf zebrafish rely exclusively on cones for vision (38) . Emixustat is a potent RPE65 inhibitor; while targets of fenretinide include DES1 (the putative isomerase II) (32) and retinol-binding protein 4 (Rbp4) in blood (34) . Larvae were raised under normal cyclic light conditions (14 h light, 10 h dark) for the duration of the experiment and treated with emixustat or fenretinide from 3 dpf. Drug was replenished at 4 dpf, and OKR analysis completed at 5 dpf between ZT 2.5 -ZT 6.5 ( Figure 1A) . Surprisingly, late photopic vision was unaffected in 5 dpf larvae treated with up to 50 μM emixustat (24.3 ± 4.9 saccades per minute) ( Figure 1B) . In contrast, larvae treated with 10 μM fenretinide displayed significantly fewer (P<0.001) saccades per minute (7.7 ± 5), in comparison to vehicle controls (24.2 ± 8.2) ( Figure 1B) . Wholemount images reveal that 5 dpf larvae treated with emixustat or fenretinide fail to inflate their swim bladder, but otherwise have normal gross morphology ( Figure 1C ). Figure 1D depicts potential targets of emixustat and fenretinide in zebrafish. Zebrafish have three rpe65 isoforms, two of which are expressed in the eye (20, 39) . Emixustat may inhibit RPEexpressed rpe65a or Müller-cell expressed rpe65c ( Figure 1D ). Fenretinide may inhibit DES1 isomerase activity in Müller cells/RPE, or inhibit uptake of atROL from the serum by blocking Rbp4-Transthyretin (TTR) interactions. In summary, in cyclic lighting conditions a broad-spectrum visual cycle inhibitor impairs late photopic vision, whereas a selective inhibitor of the canonical visual cycle did not affect vision.
In dark adapted zebrafish, emixustat blocks immediate photopic vision and fenretinide exerts an additive effect
As Rpe65 is important for chromophore regeneration under dark conditions, we tested the visual cycle inhibitors in dark-adapted zebrafish larvae wherein larvae were raised under normal cyclic light conditions until 3 dpf, then treated with drug under constant dark conditions from 3-5 dpf. Visual behavior analysis was performed at 5 dpf between ZT 2.5 and ZT 6.5, wherein larvae were individually removed from wells and immediately subjected to OKR following a two-day dark adaptation (Figure 2A ). Doseresponse and dose-frequency studies revealed that 50 μM emixustat added at day 3 and replaced at day 4 caused the most significant reduction in OKR saccade number/minute (7.1 ± 4.6, p<0.001) compared to vehicle controls (20.9 ± 5) ( Figure 2B ). Under dark conditions, larvae treated with 10 μM fenretinide displayed a ~6fold reduction in the ability to track 11 cm thick rotating stripes, whereas larvae treated with 50 μM emixustat had a ~2.5-fold decrease in OKR. Interestingly, when both isomerase inhibitors were combined, immediate photopic vision was completely abolished (1.2 saccades/minute, p<0.001) and reduced by ~22 fold, compared to vehicle controls (26.8 saccades per minute). ( Figure 2C ). Larvae treated with emixustat and fenretinide in the dark were morphologically normal, other than they did not inflate their swim bladder ( Figure 2D) as also observed under a normal light/dark cycle ( Figure 1C ). An uninflated swim bladder is commonly observed in visually compromised zebrafish larvae (40, 41) . Interestingly, neither 50 μM emixustat nor 10 μM fenretinide induced obvious changes in retinal histology, particularly the photoreceptor outer segment structure and RPE, compared to vehicle controls ( Figure 2E -G, 2E'-2G'). Furthermore, double cones stained with zpr-1 appear unaffected by fenretinide or emixustat treatment ( Figure 2E ''-2G''). Thus, emixustat impaired immediate photopic vision following dark adaptation (Figure 2A and C) but not late photopic vision ( Figure 1B) , while fenretinide inhibited both immediate and late photopic vision.
Visual cycle inhibitors modulate the profile of key retinoids in zebrafish
To assess the pharmacological specificity of the phenotypes in zebrafish, we measured the content of visual retinoids in zebrafish larval heads following pharmacological visual-cycle inhibition.
Animals genetically or pharmacologically devoid of functional visual cycles can present with significantly altered levels of retinoids in the eye and liver (3, 20, 24, 26, 42, 43) . In agreement with the impaired immediate photopic vision we observe in zebrafish, we observed a significant reduction in 11cRAL, 11cROL and the 11cRE, 11-cisretinyl palmitate (11cRP), following emixustat and fenretinide treatment, alone or in combination (p<0.001) ( Figure 3B ). Rpe65 uses atREs as its substrate, therefore, elevated levels could be expected in the presence of emixustat (2) . Interestingly, atROL (23.2 ± 3.8 pmole/mg, p<0.01) and were significantly reduced in fenretinide-only treated larvae compared to the vehicle control (70.5 ± 27.3 and 20.8 ± 2.3 pmole/mg, respectively). These data suggest that emixustat and fenretinide impair immediate photopic vision following dark adaption in zebrafish by reducing 11cRAL levels.
Supplementation with exogenous 9cRAL significantly improves immediate photopic vision in emixustat and fenretinide-treated larvae
As cone function is partially restored in Rpe65 -/mice following treatment 9cRAL, a functional analogue of 11cRAL (44), we measured cone vision following treatment with exogenous 9cRAL. Larvae were treated with emixustat and/or fenretinide under dark-adapted conditions as described above (Figure 2A ). In addition, larvae were treated with 9cRAL four hours following treatment with emixustat and/or fenretinide at both 3 and 4 dpf ( Figure 4A ). Immediate photopic vision in emixustat-treated larvae supplemented with 9cRAL improved significantly (16.1 ± 6.7 saccades per min, p<0.001), compared to emixustat-treatment alone (10.5 ± 4.8 saccades per min) ( Figure 4B ). We also observed approximately two-fold (6.5 ± 5.5 saccades per min, p<0.01) improved cone vision in fenretinide treated larvae following supplementation with 9cRAL ( Figure 4B ). 9cRAL supplementation improved vision in emixustat plus fenretinide-treated larvae approximately five-fold compared to emixustat and fenretinide-treated larvae without 9cRAL supplementation (5.3 vs 4.2 saccade per minute, respectively) ( Figure  4B ). No gross morphological changes were observed in larvae treated with 9cRAL in combination with fenretinide alone or fenretinide plus emixustat ( Figure 4C ). Interestingly, larvae treated with emixustat and 9cRAL inflated their swim bladders ( Figure 4C) , a characteristic not observed in larvae treated with emixustat alone ( Figure 2D ). Finally, treatment of larvae with exogenous 9cRAL altered retinoid profiles at 5 dpf ( Figure 4D ). All 9-cis retinoids (9cRP, 9cROL and 9cRAL) and atRP significantly increased in emixustat and 9cRAL-treated larvae, compared to emixustat alone. Presence of small amounts of 9cRAL in samples not treated with exogenous chromophore is most likely a result of thermal isomerization ( Supplementary  Figure 1) . Interestingly, no significant increase was observed in 11cRAL profile following 9cRAL supplementation. Thus, the reduction in immediate photopic vision in emixustat and fenretinide-treated larvae results not from toxic effects, but rather from visual cycle inhibition.
Early photopic vision recovers in emixustattreated larvae following exposure to light
Recent studies proposed the non-canonical visual cycle to rely on a Rpe65-independent isomerization event which relies on RGR-opsin and occurs during sustained exposure to visible light (18) . We hypothesized that exposure of larvae to light for 30 minutes following a prolonged dark adaptation may activate the alternative pathway and modulate the impaired visual behavior in larvae treated with emixustat and fenretinide under dark-adapted conditions ( Figure 2C) . At 5 dpf, between ZT 2.5 -ZT 6.5, larvae were subjected to our standard OKR assay immediately after dark adaptation for two days (0 minutes) or following 30 minutes subsequent exposure to ambient light ( Figure 5A ). Pretreatment with 50 μM emixustat partially suppressed immediate photopic vision in darkadapted larvae (11.4 ± 7.6 saccades per minute, p<0.001) compared to vehicle controls (17.3 saccades per minute) ( Figure 5B ). In contrast, pre-treatment with 10 µM fenretinide virtually abolished immediate cone photopic vision in dark-adapted larvae (1.7 ± 3 saccades per minute, p<0.0.001) compared to the vehicle control (17.3 ± 4.5 saccades per minute) ( Figure  5B ). To help discriminate if fenretinide acts via Rbp4 or Des1, A1120, a potent Rbp4 inhibitor was tested. Similar to fenretinide, A1120 suppressed immediate cone photopic vision (10.2 ± 6.6 saccades per minute). Subsequent exposure of untreated larvae to 30 minutes of light had minimum effect on early cone visual function versus untreated, dark-adapted larvae ( Figure 5B) .
Interestingly, early photopic vision in emixustat-treated larvae was indistinguishable from vehicle-only treated larvae after 30-minutes exposure to light ( Figure 5B) , despite lower 11cRAL levels in larvae treated with emixustat ( Figure 5C ). Pre-treatment of larvae with fenretinide virtually abolished cone vision following 30 minutes of light exposure, similar to fenretinide-treated, dark-adapted larvae ( Figure 5B) . Surprisingly, early photopic vision in A1120-treated larvae recovered to vehicle control levels (21 ± 5 saccades per minute) indicating that the block in early photopic vision observed following fenretinide treatment is not a result of inhibiting Rbp4 ( Figure 5B) .
The relatively normal cone OKRs in emixustat-treated larvae following light exposure raised the question if this correlated with increased 11cRAL chromophore levels.
Retinoid levels were profiled in emixustattreated larval heads at 0 and 30 minutes of light exposure ( Figure 5C ). Although vision recovered following 30 minutes light exposure ( Figure 5B ), 11cRAL levels surprisingly did not change. Interestingly, atRAL levels returned to that of the vehicle control following 30 minutes indicating photoisomerization of light sensitive chromophore and activation of the phototransduction cascade.
As early photopic vision, in the presence of emixustat, recovered following exposure to ambient light for 30 minutes, there was a possibility of light-induced degradation or inactivation of emixustat. To test this possibility, we performed mass spectrometry analysis of emixustat before and after light exposure. No change in the relative abundance of the ion corresponding to emixustat (m/z = 263.81-264.26) was observed ( Figure 5D ). NMR analysis also demonstrated no chemical change to emixustat upon exposure to visible light. (Figure 5E ).
To confirm that early photopic vision was not mediated by reactivation of RPE65, larvae were treated in the dark with emixustat from 3 dpf and emixustat was removed at 5 dpf under dim red light, 30 minutes before OKR analysis at ZT 2.5-ZT 6.5. OKR was conducted at 0-and 30-minutes post light exposure ( Figure 6A ). As before, emixustat-treated larvae presented with a significantly reduced immediate photopic vision following dark adaptation (13.8 ± 6.1 saccades per minute, p=0.0003) which recovered 30 minutes post light exposure (23.4 ± 6.5, p<0.0001) but not following 30 mins of removal of emixustat alone ( Figure 6B ). Retinoid analysis revealed a reduction in 11cRAL which did not recover following a 30minute absence of emixustat and/or 30 mins light exposure ( Figure 6C) . A significant increase in atRP in emixustat-treated larvae in both 0-and 30-minute groups reaffirms Rpe65 inhibition ( Figure 6C) . In summary, while emixustat-treated wildtype larvae display impaired immediate photopic vision, larvae can regain vision following 30 minutes of light exposure. This light-dependent recovery of early photopic vision is not due to Rpe65 isomerase activity.
Des1 is not required for cone photopic vision in zebrafish at 5 dpf
Controversially, previous studies implicated DES1 as the isomerase II in regeneration of cone visual pigments through the intraretinal visual cycle (15) . To test if degs1 is an important modulator of cone photopic vision, we created degs1 -/zebrafish using CRISPR/Cas9 by engineering a 484 bp deletion in exon 2 ( Figure  7A ). Expression of degs1 was analyzed with primers which i) span the deletion (primer set 2) or ii) nested within the deleted site (primer set 3) ( Figure 7A ). Primer set 2 amplified a lower band of 61 bp indicating the presence of the transcript with deletion, however, it did not amplify the upper (537 bp) product observed in wildtype and degs1 +/samples ( Figure 7B ). Moreover, when primer set 3 were used, a 162 bp product is seen in wildtype and degs1 +/lanes whereas no product was amplified from degs1 -/samples ( Figure 7B) . No gross morphological differences were observed in degs1 -/larvae at 5 dpf, compared to their unaffected siblings ( Figure 7C ). Late photopic vision at ZT 2.5 -ZT 6.5 is not significantly affected in degs1 -/larvae (18.5 ± 5.4 saccades per minute) at 5 dpf compared to unaffected degs1 +/+ or degs1 +/siblings (17.1 ± 5.3 saccades per minute) ( Figure 7D-E) . We randomly drug treated offspring from a degs1 +/incross with emixustat and incubated in dark ( Figure 7F ). Interestingly, neither immediate nor early photopic vision is significantly affected between the populations treated with vehicle or 50 μM emixustat ( Figure  7G) . A genotyped sample of each group validated the normal photopic response of degs1 -/larvae ( Figure 7H ).
RPE-expressed zebrafish rlbp1b is not required for cone photopic vision
Co-immunoprecipitation experiments revealed that RLBP1-encoded CRALBP interacts with DES1 and increases the rate of 11cROL synthesis (15) . Zebrafish rlbp1 has subfunctionalized, with rlbp1a expressed in Muller cells and rlbp1b expressed in the RPE (25, 26) . Here, a zebrafish knockout of RPE-expressed rlbp1b was created using CRISPR/Cas9 which introduced a 1440 bp deletion across exon 2 and 3 ( Figure 8A) . Following rlbp1b knockout, rlbp1b gene expression was completely abolished (P<0.0001) in rlbp1b -/-F 2 larval eyes. (Figure 8C ). Gross morphology of rlbp1b -/larvae is identical to their siblings at 5 dpf ( Figure 8D) . Previous studies report a reduction in cone vision and function following Rlbp1b knockdown (25, 26) however here, no differences in immediate (p=0.59), early (p=0.9) or late photopic vision (p=0.24) were observed when tested under standard OKR conditions ( Figure  8E-F) .
Discussion
Many daily tasks are dependent on the ability of the eye to functionally adapt to changes in light. Vision in well-lit environments is known as photopic vision and is mediated by cone photoreceptors (45) . Little is known regarding the biological processes underpinning functional photopic vision. Here, we apply chemical biology and genetics to dissect the contribution of light, retinoids, retinoid carrier proteins and retinoid isomerases to photopic vision i) immediately following dark adaptation, ii) after 30 minutes of light or iii) after ~4-6 hours of light. We exploited emixustat for its chemical ability to scavenge retinal and inhibit the RPE65 isomerase (26) . Likewise, fenretinide causes depletion of vitamin A by disrupting the retinoldependent binding of RBP4 to transthyretin (35) , and also inhibits the DES1 isomerase (31) (32) (33) . A1120 is a more-selective RBP4 antagonist.
Immediate and late cone photopic vision depend on different visual cycle pathways
The ray-finned fish lineage, including zebrafish, underwent whole-genome duplication resulting in two paralogues of many teleost genes (46) . In zebrafish, Rpe65a is exclusively expressed in the RPE whereas a contentious Rpe65c isoform was localized to retinal Müller glia (39) . Based on this expression pattern and the requirement of mammalian cones on both the RPE and intraretinal visual cycles for complete dark adaptation (47), we predicted that emixustat could impair both immediate and possibly also early/late cone-based vision. Although emixustat inhibited cone responses immediately following exposure to light, treated larvae had normal OKR responses after prolonged light exposure. This agrees with previous genetic studies demonstrating OKR contrast sensitivity is unaffected in Rpe65a knockdown larvae raised under normal lighting conditions (20) , but implicates RPE-specific Rpe65a in immediate photopic vision after dark adaptation. However, we cannot unequivocally exclude a role for zebrafish Rpe65c in Müller glia in the immediate response.
Retinoid profiles are altered in dark-adapted zebrafish larvae treated with visual cycle isomerase inhibitors
Retinoid analysis from dark-adapted zebrafish larvae show reduced 11-cis-retinoids (11cROL, 11cRAL and 11cRP) with emixustattreatment. Fenretinide also dose-dependently suppressed immediate photopic vision. However, although 11-cis-retinoid levels were lower in fenretinide-versus vehicle-treated larvae, the degree of suppressed vision was less than with emixustat. Levels of atROL, atRAL and atRP were also suppressed in fenretinideversus vehicle-treated larvae, an effect not observed in emixustat-treated larvae.
Exogenous 9cRAL supplementation restores immediate photopic vision following visual cycle inhibition
Treatment with exogenous 9cRAL recovers ERG responses in Rpe65 -/mice and functional vision in Rpe65-deficient dogs, establishing its potential as a chromophore replacement therapy (30, 47, 48) . In agreement, immediate photopic vision significantly improved emixustat and/or fenretinide-treated larvae supplemented with 9cRAL. Thus, the impaired cone vision we observe is a specific pharmacological effect on the visual cycle and not a result of ocular toxicity. Additionally, fenretinide-treated larvae display impaired immediate photopic vision despite relatively high 11cRAL levels. The improvement of vision with exogenous 9cRAL suggests that the 11cRAL stores present may be unavailable to cones in fenretinide-treated larvae. Improved vision in emixustat-treated larvae supplemented with 9cRAL was not coupled to increased 11cRAL levels. Instead, all 9-cis retinoid profiles (9cRAL, 9cROL and 9cRP) were significantly increased, indicating that the recovered vision may be mediated by iso-opsins.
Differential requirements of Rpe65 for immediate and early cone-based photopic vision
Since emixustat did not affect late photopic vision in zebrafish, we investigated if impaired immediate photopic vision in darkadapted animals could recover in a lightdependent, Rpe65-independent manner. Pharmacological RPE65 inhibition significantly reduces 11cRAL levels in multiple models e.g. by Ret-NH 2 in zebrafish (20) , by emixustat in mice (26) and by emixustat or fenretinide in ex vivo RPE microsomes (32) . Here as expected, dark-adapted, wildtype larvae treated with emixustat display a ~10-fold reduction in 11cRAL. Interestingly, 11cRAL levels did not recover following 30 mins light exposure despite recovery of early photopic vision. A reduction in total retinoid was observed indicating that emixustat may be trapping atRAL and forming unknown or undetectable conjugates. Consistent with light overcoming emixustat-mediated visual impairment, atRAL was restored to levels similar to vehicle controls 30 minutes following light exposure, consistent with initiation of phototransduction. However, that photopic vision recovers in the light, surmounting emixustat, without an associated increase in 11cRAL levels is intriguing. Potentially, the small amount of 11cRAL available to the photopic cycle activates cone opsins in a steady state and is sufficient to sustain a stable visual response during this 30-minute light exposure. As REs support cone function (49) and are a significant source for cone pigment regeneration (50) one possibility is that 11cRP reserves were utilized upon exposure to light. However, in line with previous studies employing RPE65 inhibitors in zebrafish (49) , emixustat treatment completely blocked generation of 11cRP both in the dark and light. An alternative RPE65independent isomerization event for cone pigment regeneration was recently described in mice (18) . This cone regeneration mechanisms involves Müller glia-expressed RGR-opsin, which converts atROL to 11cROL upon visible light exposure. In RPE cells, RGR opsin also affects light-dependent mobilization of atREs, suggesting it diverts substrate away from Rpe65 in RPE cells toward the Müller cell visual cycle (51) .
Using genetic and pharmacological approaches, we investigate the molecular mechanisms mediating this 30-minute switch from a light-independent visual cycle, supporting immediate photopic vision, to a lightdependent visual cycle, supporting early photopic vision. When wildtype larvae were treated with the potent RBP4 antagonist A1120 alone immediate photopic vision was reduced but recovery of early photopic vision was equivalent to vehicle controls. This indicates that RBP4 is required for the non-photopic visual cycle but not for the photopic visual cycle. Furthermore, knockout of degs1 -/in zebrafish showed no modulation of immediate, early or late photopic vision suggesting Des1 is not essential for either the photopic or non-photopic visual cycles. The discrepancies between Des1 pharmacological inhibition and the genetic model may be attributed to off-target effects and genetic compensation, respectively and illustrates the requirement to use these complementary approaches in parallel. Mammalian CRALBP forms a complex with DES1 (15) and is reported to regulate the cone visual cycle. Deletion of CRALBP in mice results in reduced photopic ERG responses (52) . Adenovirus-mediated delivery of Müller cell CRALBP restored cone-driven responses. Here, knockout of the RPE-expressed rlbp1b paralogue in zebrafish did not affect immediate or early photopic vision in larvae treated with emixustat.
Significantly, fenretinide and emixustat hydrochloride have reached phase II and III clinical trials, respectively, for use in geographic atrophy. Night blindness and dry eye are sideeffects of fenretinide treatment (53) . Our data demonstrates that fenretinide also impairs photopic vision, thus, concerns arise over potential adverse drug reactions in the clinic with fenretinide use to treat diseases such as geographic atrophy, cancer, acne, cystic fibrosis and psoriasis. Likewise, emixustat is now in Phase III clinical trial for the inherited retinal degeneration Stargardt disease with the intention of suppressing retinoid cycling (37) . We have shown that the photopic visual cycle overcomes emixustat which may have significant impact on clinical outcomes.
In summary, pharmacological and genetic models of visual cycle modulation enhanced our knowledge of the fundamental mechanisms of cone photopic vision. Differential stages of vertebrate photopic vision demand differential biochemical pathways, in light and dark. Rpe65 regenerates photopigment required by cones for immediate photopic response. In contrast, during sustained light, Rpe65 appears redundant to a light-dependent regeneration of visual pigments, a process whereby diminished 11cRAL levels are sufficient for photopic vision.
Experimental Procedures
Zebrafish Breeding and Maintenance
Adult zebrafish were maintained in a 14-hour light, 10-hour dark cycle in a recirculating water system at 28 
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Generation of mutant zebrafish
Custom crRNA guides, containing a NGG protospacer adjacent motif (PAM) were designed per gene using Benchling (www.benchling.com) CRISPR guide software. All guide sequences and PAMs are listed in Supplementary Table 1 . The Alt-R system (Integrated DNA Technologies) was used to knockout rlbp1b and degs1 in zebrafish. Briefly, 36 ng/μl crRNA and 67 ng/μl tracrRNA was complexed in nuclease-free duplex buffer by heating to 95 o C for 10 minutes. Sample was cooled to room temperature and a final working concentration of 0.5 ug/μl S. pyogenes Cas9 nuclease (Integrated DNA technologies) was added. The mixture was heated to 37 o C for 15 minutes before microinjection into wildtype embryos at one-cell stage. Injected fish were raised until adulthood and outcrossed to screen for germline transmission of the null target gene. Isogenic F 1 heterozygous adult fish were incrossed to generate homozygous F 2 mutants.
Genomic DNA extraction and polymerase chain reaction
DNA was extracted from injected F0 or germline F2 rlbp1b larvae by boiling the sample at 95 o C in NaOH (50 mM) (Sigma Aldrich, UK) before neutralizing with 1/10th Trizma Base (Sigma Aldrich, UK). The region of interest was amplified by polymerase chain reaction (PCR) using the following primers which span the rlbp1b or degs1 mutation site: rlbp1b 5'-CCACAGAGTGGAACATTTCGA-3', 5'-GATGATGCAACACTATTGCCCA-3' and 5'-ACCTTTCAGCATTCACAATCCT-3'; degs1 5'-TTCTCCATGACCTTTCAGCCC-3' and 5'-TGCTCTCACCATTGGTAGTCG-3'. Fragment sizes were run on a 1.5% agarose gel and compared against a 100 bp DNA ladder (New England Biolabs, UK).
Total RNA extraction, cDNA synthesis and RT-PCR/qPCR
At 5 dpf, ~20-50 eyes (10-25 larvae) were enucleated and stored in RNAlater (Qiagen, Germany) individually at 4 o C. Larval trunks were genotyped as previously described. Eyes were pooled and total RNA was extracted using mirVana™ miRNA Isolation Kit (ThermoFisher Scientific) as per the manufacturer's instructions. NaOAc (3M) and 100% ethanol were added to the eluted RNA, vortexed and left overnight at -20 o C. Samples were centrifuged at 14000 rpm for 60 minutes at 4 o C, supernatant removed before the pellet was resuspended in 80% ethanol and centrifugation for a further 60 minutes at 14000 rpm. Supernatant was discarded and the pellet was resuspended in ultrapure water. Total RNA concentration was quantified at 260 nm (Spectrophotometer ND-1000) and samples stored at −80°C until further use. cDNA was synthesized using PrimeScript™ RT reagent Kit (Perfect Real Time) (TAKARA, Japan). QRT-PCR reactions were made up on ice with 0.2 μl forward and reverse primer: rlbp1b 5'-TGAGCTTGCTAAAGGTGTTCAGG-3' and 5'-TCAGGATAATCCCGTCTGAAGC-3', 5 μl Sybr Green Master Mix (Thermo Fisher Scientific, Massachusetts, USA), 3.6 μl RNAsefree water and 1 μl cDNA template (12.5 ng) was added per sample. QRT-PCR cycles were carried out using the following parameters: 50°C for 2 min, 95°C for 10 min, 95°C for 15 s with 40 repeats and 60°C for 1 min on a Quant Studio 7 Flex Real-Time PCR System. To evaluate degs1 expression, the cDNA was amplified by PCR using the following primer sets: degs1 forward 2: 5'-GTCAGCACGATGGTGGT GTC -3', degs1 reverse 2: 5'-TGGAGACCCATGCCCAGCAT-3'; degs1 forward 3: 5'-GGACGTGGACATCCCCACTGA -3', degs1 reverse 3: 5'-AGCTGGATGGCCACGTTCAG -3'. Samples were run on a 1.5% agarose gel and compared against a 100 bp DNA ladder (New England Biolabs, UK).
Drug Preparation and Treatment
Wildtype, rlbp1b -/and degs1 -/larvae were raised from embryos under standard 14-hour light, 10-hour dark conditions. At 3 dpf, five larvae per well were placed in 48 well cell culture plates (Greiner Bio-one, Austria). Emixustat hydrochloride (Medchem, New Jersey, USA), fenretinide (Cayman Chemical, Michigan, USA) and A1120 (Sigma Aldrich, UK) were prepared in embryo medium and 400 μl drug solution at 1-50 µM in 0.01%-0.5% DMSO was added to the wells. For emixustat and fenretinide combinations, 1-10 μM fenretinide was added 15 mins prior to the addition of 50 μM emixustat. Larvae were initially treated at 74-76 hpf and the drug was replaced at 98-100 hpf. 10 μM 9-cis-retinal (Sigma Aldrich, UK) was added to embryo medium four hours following primary drug treatment (i.e. 78-80 hpf and 102-104 hpf). 9cis-retinal was handled under dim red light.
Visual Behavior Analysis
To measure optokinetic response (OKR), single larvae were immobilized in pre-warmed 9% methylcellulose (Sigma Aldrich, UK) and placed in the center of a rotating drum containing vertical 1 cm thick black and white stripes. The angle subtended was 0.58 rad (33.7°). The drum was rotated at 18 rpm for 30 seconds in a clockwise and 30 seconds in a counterclockwise direction. Saccadic eye movements per minute were recorded manually. All OKR measurements were performed in larvae at 5 dpf between 10 am (ZT 2.5) and 2 pm (ZT 6.5).
Histological Analysis
Larvae were fixed in glass vials containing 2.5% glutaraldehyde, 2% paraformaldehyde and 0.1% Sorenson's phosphate buffer (pH 7.3) and were placed at 4 o C. Samples were washed before post-fixation in 1% osmium tetroxide (Sigma Aldrich, UK) and dehydrated using an ethanol gradient (30%, 50%, 70%, 90%, 100%). Samples were transferred to propylene oxide (Sigma Aldrich, UK), embedded in agar epoxy resin overnight and 0.5 μm sections were cut using an ultramicrotome (Leica EM UC6). Sections were placed on glass slides and stained with toluidine blue (Sigma Aldrich, UK) for 30-60 seconds and imaged using a Leica DMLB bright field illumination microscope with a Leica DFC 480 camera attachment. For transmission electron microscopy (TEM), 0.08 µm sections were cut using a diamond knife and a Leica EM UC6 ultramicrotome. Sections were transferred to a support grid, stained with uranyl acetate and lead citrate, and imaged on a FEI-Tecnai 12 BioTwin transmission electron microscope (FEI Electron Optics). Drug treated larvae were fixed at 5 dpf with 4% paraformaldehyde (PFA; Sigma Aldrich, UK). Larvae were cryoprotected in a sucrose series before embedding in optimal cutting temperature (OCT) medium (VWR, Pennsylvania, United States). Sections were cut to 14 μm and thawmounted onto charged superfrost plus slides (Fisher Scientific, Pittsburgh, USA). Sections were rehydrated using 1X phosphate buffered saline supplemented with tween 20 (Sigma Aldrich, UK) (0.01% PBST) before blocking in 10% goat serum (Sigma Aldrich, UK) for 1 hour. Monoclonal zpr-1 was used at 1:200 (Zebrafish International Resource Center, Eugene, USA). Slides were washed before incubating with the secondary antibody (Alexa Fluor 488 anti-mouse IgG). Primary and secondary antibodies were diluted in blocking solution.
Slides were mounted using Vectashield; (Vector Laboratories, California, USA) before imaging using a Zeiss LSM510 confocal microscope (Carl Zeiss AG, Germany) with a 63X objective.
Retinoid Quantification
For retinoid analysis, 105 larvae per treatment condition at 5 dpf were euthanized in ice water before their heads were collected under dim red light. For normal-phase HPLC analysis of retinoids, all retinoid extractions were carried out under dim red light in a dark room. Zebrafish heads were stored at −80 °C, thawed on ice, and homogenized in 500 μl of phosphate buffered saline (PBS) using a glass tissue grinder (Kontes).
Protein concentration was determinated using 50 μl of sample and a Micro BCA Protein Assay Kit (Pierce, US). To the remaining 450 µL of homogenate 25 µL of 5% SDS (~0.2% SDS final concentration) and 50 µL of brine were added and samples briefly mixed. Hydroxylamine hydrochloride (500 µL of 1.0 M solution in pH 7.0 PBS) was added to generate retinal oximes and samples were vortexed and incubated at room temperature for 15 minutes. The aqueous phase was quenched and diluted using 2 ml of cold methanol. The samples were twice extracted by addition of 2 ml aliquots of hexane, brief vortexing, and centrifugation at 3000 x g for five minutes to separate the phases. Pooled hexane extracts were added to 13 x 100 mm borosilicate test tubes and evaporated to dryness under a stream of nitrogen. Dried samples were dissolved in 100 μl hexane and analyzed by normal-phase HPLC using an Agilent 1100 series chromatograph equipped with a Supelcosil LC-Si column (4.6 × 250 mm, 5 μm) using a 0.2-10% dioxane gradient in hexane at a flow rate of two mL per minute. The eluted mobile phase was analyzed using a photodiode-array detector. Spectra (210-450 nm) were acquired for all eluted peaks. The identity of eluted peaks was established by comparison to spectra and elution times of known authentic retinoid standards. Retinoid amounts were quantitated by comparing their respective peak areas to calibration curves established with retinoid standards.
Photostability of Emixustat Hydrochloride
Liquid chromatography used a Dionex Ultimate 3000 RSLC micro-LC system (Thermo Fisher Scientific, US). Separation was performed using a Thermo Acclaim RSLC 120 2.2 µm, 120 A, 1.0 x 100 mm LC column (Thermo Fisher Scientific, US). LC parameters were: elution mode: gradient (from 90% A to 90% B in 15 min), flow rate: 45 µL/min, column temperature: For Nuclear Magnetic Resonance (NMR) analysis, emixustat (7 mg) was dissolved in DMSO-d6 (600 μl) under dim red light and covered with aluminum foil until 1 H NMR and HSQC experiments were performed. The NMR tube was exposed to visible light for 30 minutes, followed by a repeat NMR analysis. 1 H NMR spectra were measured in the solvent stated at 400 MHz. Chemical shifts (δ) are quoted in parts per million (ppm) referenced to residual solvent peak (e.g., DMSO-d 6 : 1 H -2.50 ppm and 3.33 ppm).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism™ software (GraphPad, San Diego, CA). A two-tailed student's unpaired ttest was applied comparing two experimental groups. For analysis involving more than two independent groups, a one-way ANOVA and Dunnett's multiple comparison test or Bonferroni post hoc test was performed. Experiments comprised of two variables were tested for significance using a two-way ANOVA and a Bonferroni post hoc test. All data are presented as mean ± standard deviation (SD). Statistical significance was assigned to p-values of p < 0.05 = *, p < 0.01 = ** or p < 0.001 = ***. Zebrafish larvae are treated initially at 3 dpf and the drug is replaced at 4 dpf. 9cRAL is added to the medium four hours following 50 µM emixustat and/or 10 µM fenretinide treatment on both 3 dpf and 4 dpf. Larvae are incubated in the dark until OKR analysis at 5 dpf. B) Larval OKR following addition of 10 μM 9cRAL to larvae prior treated with 50 μM emixustat and 10 μM fenretinide, alone or in combination at 3 dpf and 4 dpf. Data were analyzed by unpaired, two-tailed t-tests where *=p<0.05, **=p<0.01, ***=p<0.001. ns=not significant. N=30 larvae with 3 independent biological replicates. C) Dorsal and lateral brightfield microscopy images of larvae at 5 dpf larvae treated with 50 µM emixustat and/or 10 µM fenretinide in combination with 10 μM 9cRAL. Scale bar=2 mm. D) Retinoid profiles following exogenous 9cRAL supplementation in vehicle control and emixustat-treated zebrafish larvae. Bars represent the mean±SD of three independent experiments for each condition with 105 larval heads per biological replicate. Data were analyzed by unpaired, two-tailed t-tests where *=p<0.05, **=p<0.01, ***=p<0.001. ns=not significant.
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Figure 5: Early photopic vision recovers in emixustat-treated larvae following exposure to light. A)
Schematic representation of experimental workflow. Zebrafish larvae are treated initially at 3 dpf and drug is replaced at 4 dpf. Larvae are incubated under dark conditions until analysis at 5 dpf. At 5 dpf larvae are subjected to OKR immediately following dark adaptation (0 minutes) or following 30 minutes of light (30 minutes). B) OKR of 5 dpf larvae treated with 50 µM emixustat, 50 µM A1120 or 10 µM fenretinide 0 and 30 minutes following light exposure. Data were analyzed by unpaired, two-tailed t-tests where ns=not significant, **=p<0.01 and ***=p<0.001. N=30 larvae with 3 independent biological replicates. C) Retinoid profiles of 5 dpf larvae treated with 50 µM emixustat following no light exposure (0 minutes) or 30 minutes light exposure (30 minutes). Bars represent the mean±SD of three independent experiments for each condition with 105 larval heads per biological replicate. Data were analyzed by unpaired, two-tailed t-tests where ns=not significant, **=p<0.01 and ***=p<0.001. D) Emixustat extracted ion chromatograms (at m/z 264, RT 7.1 min) and high resolution mass spectrum (m/z 264.1976 [M+H] + highlighting no change in the mass spectrometry profile of emixustat exposed to 30 minutes of light and samples which received no light (0 minutes). E) NMR light sensitivity analysis of emixustat. Emixustat was dissolved in DMSO-d 6 (600 μl) covering with aluminum foil until 1 H NMR and HSQC experiments were performed (0 minutes). The NMR tube was left exposed to visible light for 30 minutes, followed by a second NMR analysis. (30 minutes). Peaks at 2.09 ppm and 5.76 ppm correspond to acetone and dichloromethane, respectively.
Figure 6:
In the absence of light, 30 minutes alone is not sufficient to restore vision or 11cRAL levels. A) Schematic representation of experimental workflow. Zebrafish larvae are treated initially at 3 dpf and drug is replaced at 4 dpf. Larvae are incubated under dark conditions until analysis at 5 dpf. At 5 dpf, emixustat is removed under dim red light 30 minutes before larvae are subjected to OKR immediately following dark adaptation (0 minutes) or following 30 minutes light adaptation (30 minutes). B) Optokinetic response 30 minutes following removal of emixustat at 5 dpf larvae 0 and 30 minutes following light exposure. Data were analyzed by unpaired, two-tailed t-tests where ns=not significant, **=p<0.01 and ***=p<0.001. N=30 larvae with 3 independent biological replicates. C) Retinoid profiles of 5 dpf larvae treated with 50 µM emixustat. Emixustat is removed 30 minutes before dissection at 0-or 30-minutes post light exposure. Bars represent the mean±SD of three independent experiments for each condition with 105 larval heads per biological replicate. Data were analyzed by unpaired, two-tailed ttests where ns=not significant, **=p<0.01 and ***=p<0.001.
Figure 7: Des1 is not required for cone photopic vision in zebrafish at 5 dpf. A) CRISPR/Cas9
knockout strategy of degs1 in zebrafish. Both guides were targeted to exon 2 to induce a 484 bp deletion in the degs1 gene which contains 3 exons in total. Forward primer 1 (FP1) to reverse primer 1 (RP1) amplifies an 807 bp genomic DNA wildtype product or 323 bp product when deletion is present. For mRNA expression analysis we used forward primer 2 (FP2) to reverse primer 2 (RP2) which span the deletion and amplify a 537 bp wildtype product or 61 bp when the deletion is present. Forward primer 3 (FP3) to reverse primer 3 (RP3) is nested within the deletion and amplifies a 162 bp wildtype product. B) 1.5% agarose gel depicting degs1 expression in wildtype, degs1 +/or degs -/zebrafish. L = 100 bp ladder. Red box highlights the 61 bp product expected following a deletion event with primer set 2 in degs1 +/or degs1 -/samples. C) Dorsal and lateral brightfield microscopy images of untreated degs1 sibling (degs1 +/+ or degs1 +/-) and degs1 -/larvae at 5 dpf. Scale bar = 2 mm. D) Schematic representation of experimental workflow. degs1 -/larvae are incubated under standard lighting conditions (14-hour light, 10-hour dark) until OKR analysis at 5 dpf. E) OKR of degs1 -/and sibling larvae at 5 dpf larvae following standard 14hour light, 10-hour dark conditions. Data were analyzed by an unpaired, a two-tailed t-test where ns= not significant (p>0.05). N>30 larvae with 3 independent biological replicates. F) Schematic representation of Figure 8 : RPE-expressed rlbp1b is not required cone photopic vision in zebrafish at 5 dpf. A) CRISPR/Cas9 knockout strategy of RPE-expressed rlbp1b. Guides were targeted to exon 2 and exon 3 to induce a 1440 bp deletion in rlbp1b which contains 7 exons. Forward primer 1 (FP1) to reverse primer 1 (RP1) amplifies a 1688 bp wildtype product or 248 bp product when deletion is present. A poison forward primer (FP2) was designed in the middle of the deleted region to amplify a 469 bp wildtype product. B) An agarose gel (1.5%) depicting the presence of the deletion in individual F2 larval genomic DNA. A wildtype control was used to amplify the upper band (469 bp) and gDNA from the injected F0 parent fin was used as a positive control to amplify both upper and lower bands (mosaic). L = 100 bp ladder. C) Gene expression analysis of rlbp1b in rlbp1b -/eyes. Data were analyzed by unpaired, two-tailed t-tests where **=p<0.01 and ***=p<0.001. Three independent biological replicates performed with at least 10 larvae per replicate. D) Dorsal and lateral brightfield microscopy images of untreated wildtype, rlbp1b +/and rlbp1b -/larvae at 5 dpf. Scale bar = 2 mm. E) Schematic representation of experimental workflow. rlbp1b -/larvae are incubated under standard lighting conditions (14-hour light, 10-hour dark) until OKR analysis at 5 dpf. F) Late photopic vision as measured by OKR in 5 dpf larvae. Data were analyzed by an
